CD40 AND ITS LIGAND, AN ESSENTIAL LIGAND RECEPTOR PAIR FOR THYMUS-DEPENDENT B-CELL ACTIVATION
被引:310
作者:
NOELLE, RJ
论文数: 0引用数: 0
h-index: 0
机构:
BRISTOL MYERS SQUIBB PHARMACEUT RES INST,SEATTLE,WA 98121BRISTOL MYERS SQUIBB PHARMACEUT RES INST,SEATTLE,WA 98121
NOELLE, RJ
[1
]
LEDBETTER, JA
论文数: 0引用数: 0
h-index: 0
机构:
BRISTOL MYERS SQUIBB PHARMACEUT RES INST,SEATTLE,WA 98121BRISTOL MYERS SQUIBB PHARMACEUT RES INST,SEATTLE,WA 98121
LEDBETTER, JA
[1
]
ARUFFO, A
论文数: 0引用数: 0
h-index: 0
机构:
BRISTOL MYERS SQUIBB PHARMACEUT RES INST,SEATTLE,WA 98121BRISTOL MYERS SQUIBB PHARMACEUT RES INST,SEATTLE,WA 98121
ARUFFO, A
[1
]
机构:
[1] BRISTOL MYERS SQUIBB PHARMACEUT RES INST,SEATTLE,WA 98121
来源:
IMMUNOLOGY TODAY
|
1992年
/
13卷
/
11期
关键词:
D O I:
10.1016/0167-5699(92)90068-I
中图分类号:
R392 [医学免疫学];
Q939.91 [免疫学];
学科分类号:
100102 ;
摘要:
The discovery of CD40 and its ligand, gp39, have created new perspectives on the activation of resting B cells by T(H) cells. Here, Randolph Noelle, Jeffrey Ledbetter and Alejandro Aruffo describe how these molecules were characterized and, from recent findings, examine their relevance to immune activation.